Olusanya Rufai Md - Brooklyn, New York 11238

Olusanya Rufai Md is categorized under Doctors in Brooklyn, NY .

Business Name: Olusanya Rufai Md
Contact Person: Olusanya Rufai
Address: 753 Classon Avenue Apartment Lj, Brooklyn, New York 11238
Phone Number: (620) 532-1835
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Smith Edward F MD - Brooklyn, NY 11238
Joseph F Ewa MD - Brooklyn, NY 11238
Irving G Kroop Md - Brooklyn, NY 11238
Stowell Charles MD - Brooklyn, NY 11238
Manhattan Medical Pratice Pc - Brooklyn, NY 11238
Ifill Owen MD - Brooklyn, NY 11238
Fong Dean MD - Brooklyn, NY 11238
Crevecoeur Evans MD - Brooklyn, NY 11238
Dimaggio Dina MD - Brooklyn, NY 11238
Philip M Hendel - Brooklyn, NY 11238
Calderone Philip G MD - Brooklyn, NY 11238
S J Danziger Md - Brooklyn, NY 11238
Kurz Larry S MD - Brooklyn, NY 11238
D'Alto Michael MD - Brooklyn, NY 11238
Gerald Jahng Md - Brooklyn, NY 11238
Rosemary Jackson - Brooklyn, NY 11238
Millett & Pinckney - Brooklyn, NY 11238
Sameer Rafela - Brooklyn, NY 11238
Tutino Jody M L MD - Brooklyn, NY 11238
Sunrise Medical Group - Brooklyn, NY 11238

The company Olusanya Rufai Md provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Olusanya Rufai Md, and the business now earns $100.000 to $499.999 per annum.

Olusanya Rufai Md was launched in 2009 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Olusanya Rufai Md, please call Olusanya Rufai with the phone number (620) 532-1835 or visit its single location at 753 Classon Avenue Apartment Lj in Brooklyn, New York 11238.

The location of the single location can also be found using the coordinates 40.674702,-73.959942. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.